• Measuring interobserver variation in a pathology EQA scheme using weighted kappa for multiple readers 

  Wright, KC; Melia, J; Moss, S; Berney, DM; Coleman, D; Harnden, P (B M J PUBLISHING GROUP, 2011-12)

  Background A Urological Pathology External Quality Assurance (EQA) Scheme in the UK has reported observer variation in the diagnosis and grading of adenocarcinoma in prostatic biopsies using basic kappa statistics, which ...
• Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification 

  Matutes, E; Pickl, WF; van t Veer, M; Morilla, R; Swansbury, J; Strobl, H; Attarbaschi, A; Hopfinger, G; Ashley, S; Bene, MC; Porwit, A; Orfao, A; Lemez, P; Schabath, R; Ludwig, W-D (AMER SOC HEMATOLOGY, 2011-03-17)

  The features of 100 mixed-phenotype acute leukemias (MPALs), fulfilling WHO 2008 criteria, are documented. Myeloid and T-lineage features were demonstrated by cytoplasmic myeloperoxidase and CD3; B-lineage features were ...
• A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. 

  García-Closas, M; Hein, DW; Silverman, D; Malats, N; Yeager, M; Jacobs, K; Doll, MA; Figueroa, JD; Baris, D; Schwenn, M; Kogevinas, M; Johnson, A; Chatterjee, N; Moore, LE; Moeller, T; Real, FX; Chanock, S; Rothman, N (2011-04)

  The arylamine N-acetyltransferase 2 (NAT2) slow acetylation phenotype is an established risk factor for urinary bladder cancer. We reported earlier on this risk association using NAT2 phenotypic categories inferred from ...
• A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial 

  Kitchener, HC; Gilham, C; Sargent, A; Bailey, A; Albrow, R; Roberts, C; Desai, M; Mather, J; Turner, A; Moss, S; Peto, J (ELSEVIER SCI LTD, 2011-04)

  Background: The additional sensitivity of HPV testing compared with cytology could permit extended cervical screening intervals. We wished to determine, through a further (third) round of screening in the ARTISTIC trial, ...
• Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 

  Bene, MC; Nebe, T; Bettelheim, P; Buldini, B; Bumbea, H; Kern, W; Lacombe, F; Lemez, P; Marinov, I; Matutes, E; Maynadie, M; Oelschlagel, U; Orfao, A; Schabath, R; Solenthaler, M; Tschurtschenthaler, G; Vladareanu, AM; Zini, G; Faure, GC; Porwit, A (NATURE PUBLISHING GROUP, 2011-04)

  The European LeukemiaNet (ELN), workpackage 10 (WP10) was designed to deal with diagnosis matters using morphology and immunophenotyping. This group aimed at establishing a consensus on the required reagents for proper ...

View more